Published in Am J Epidemiol on October 01, 1994
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med (2000) 5.12
Nicotine metabolism and intake in black and white smokers. JAMA (1998) 5.03
Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med (1983) 4.80
Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr (1981) 3.72
Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association. Tob Control (1998) 3.47
Cotinine disposition and effects. Clin Pharmacol Ther (1983) 3.26
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest (1996) 3.13
Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med (1986) 2.87
Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther (2011) 2.75
Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J (Clin Res Ed) (1986) 2.75
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health (1988) 2.63
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke (2001) 2.60
Drug interactions with tobacco smoking. An update. Clin Pharmacokinet (1999) 2.52
Apparent underreporting of cigarette consumption among Mexican American smokers. Am J Public Health (1990) 2.47
Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther (1984) 2.43
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Environmental and biological monitoring for lead exposure in California workplaces. Am J Public Health (1990) 2.16
Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health (1988) 2.16
Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther (1982) 2.12
Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biol Mass Spectrom (1991) 2.10
Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation (1998) 2.00
Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation (1989) 1.93
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry (2006) 1.89
Nicotine blood levels and subjective craving for cigarettes. Pharmacol Biochem Behav (2000) 1.87
Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend (1993) 1.84
Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf (2001) 1.84
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clin Pharmacol Ther (2009) 1.83
Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med (1995) 1.82
Clonidine for smoking cessation. Cochrane Database Syst Rev (2004) 1.80
Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis (1992) 1.79
Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet (1978) 1.79
Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther (2007) 1.70
Association of weight loss and weight fluctuation with mortality among Japanese American men. N Engl J Med (1995) 1.67
Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther (1982) 1.60
Reducing tobacco addiction through tobacco product regulation. Tob Control (2004) 1.59
Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol (1997) 1.56
Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol (1987) 1.54
Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther (1997) 1.53
Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health (1999) 1.52
Toward a comprehensive long term nicotine policy. Tob Control (2005) 1.52
Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther (2011) 1.52
Social factors and minor psychiatric disorder in middle-aged men: a validation study and a population survey. Psychol Med (1991) 1.48
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med (1989) 1.48
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res (2004) 1.48
Delayed health hazards of pesticide exposure. Annu Rev Public Health (1986) 1.45
Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes. JAMA (1986) 1.45
Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther (1987) 1.45
Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine. Drug Saf (1992) 1.43
Effect of metoclopramide on gastric emptying during labour. Br Med J (1973) 1.42
Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. Am J Respir Crit Care Med (2001) 1.42
Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol (1982) 1.41
Changes in plasma catecholamines after tonic-clonic seizures. Neurology (1984) 1.40
The use of biologic fluid samples in assessing tobacco smoke consumption. NIDA Res Monogr (1983) 1.39
Phencyclidine poisoning. JAMA (1975) 1.37
A proposal to develop meaningful labeling for cigarettes. JAMA (1994) 1.35
Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther (1985) 1.35
Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke (1996) 1.33
Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol (1997) 1.32
Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users. Clin Pharmacol Ther (1981) 1.31
Recent studies of nicotine metabolism in humans. Pharmacol Biochem Behav (1988) 1.30
Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther (2000) 1.26
Clinical pharmacology of nicotine. Annu Rev Med (1986) 1.25
Nicotine exposure among nondependent smokers. Arch Gen Psychiatry (1990) 1.24
Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin Pharmacol Ther (1993) 1.20
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care (1999) 1.18
Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes Care (1996) 1.18
Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest (1994) 1.16
How a cigarette is smoked determines blood nicotine levels. Clin Pharmacol Ther (1983) 1.16
Use of medroxyprogesterone acetate as a contraceptive in conjunction with early postpartum rubella vaccination. Br Med J (1973) 1.16
Environmental and drug-induced hyperthermia. Pathophysiology, recognition, and management. Emerg Med Clin North Am (1984) 1.16
Physical activity and incidence of diabetes: the Honolulu Heart Program. Am J Epidemiol (1995) 1.15
Workshop on problem-based learning as a method for teaching clinical pharmacology and therapeutics in medical school. J Clin Pharmacol (1992) 1.15
Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am J Ind Med (2001) 1.14
Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. Clin Nephrol (1979) 1.13
Nicotine elimination and tolerance in non-dependent cigarette smokers. Psychopharmacology (Berl) (1992) 1.12
Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther (1975) 1.12
Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol (1996) 1.12
Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr (1992) 1.11
Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res (1998) 1.11
Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clin Pharmacol Ther (1984) 1.11
Cardiopulmonary catastrophes in drug-overdosed patients. Med Clin North Am (1979) 1.10
Nicotine and carbon monoxide intake from high- and low-yield cigarettes. Clin Pharmacol Ther (1984) 1.10
Clinical pharmacology of nicotine. Clin Dermatol (1998) 1.09
Factors associated with variations in pulmonary function among elderly Japanese-American men. Chest (1997) 1.08
Environmental influences on helminthiasis and nutritional status among Pacific schoolchildren. Int J Environ Health Res (2004) 1.08
A standardized benchmark approach to the use of cancer epidemiology data for risk assessment. Toxicol Ind Health (1985) 1.07
Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J Chromatogr (1993) 1.06
Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. Clin Pharmacol Ther (2007) 1.06
Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther (1980) 1.06
Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. Prog Brain Res (1989) 1.06
Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation (1991) 1.05
Distribution and correlates of lipids and lipoproteins in elderly Japanese-American men. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol (1996) 1.04
Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol. Clin Pharmacol Ther (1977) 1.04
Disposition kinetics and effects of menthol. Clin Pharmacol Ther (1999) 1.03
Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. Circulation (1996) 1.03
Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide. Chem Res Toxicol (1992) 1.03
Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther (1988) 1.03
Relative weight, weight change, and risk of coronary heart disease in the Honolulu Heart Program. Am J Epidemiol (1998) 1.02
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men. Am J Cardiol (2000) 1.02
Blood cotinine levels as indicators of smoking treatment outcome. Clin Pharmacol Ther (1984) 1.02